Veracyte, Inc. (FRA:12V)

Germany · Delayed Price · Currency is EUR

30.60

-0.20 (-0.65%)

Last updated: Feb 20, 2026, 8:04 AM CET

Revenue by Segment

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
Diagnostic Products and Biopharmaceutical Services	445.76M	361.05M	296.54M	219.51M	117.48M
Diagnostic Products and Biopharmaceutical Services Growth	23.46%	21.76%	35.09%	86.85%	-2.40%
Total	445.76M	361.05M	296.54M	219.51M	117.48M
Total Growth	23.46%	21.76%	35.09%	86.85%	-2.40%

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
United States	423.54M	334.53M	262.92M	200.98M	109.61M
United States Growth	26.61%	27.23%	30.82%	83.35%	-8.01%
International	22.23M	26.53M	33.61M	18.53M	7.87M
International Growth	-16.21%	-21.08%	81.38%	135.51%	547.65%
Total	445.76M	361.05M	296.54M	219.51M	117.48M
Total Growth	23.46%	21.76%	35.09%	86.85%	-2.40%

Source: S&P Global Market Intelligence.